COIL Share Price Performance
UK£0.085
-0.07 (-46.88%)
Price UK£0.085
Share Pricen/a
Coiled Therapeutics plc Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
COIL Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Coiled Therapeutics plc Key Details
About COIL
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Coiled Therapeutics plc operates as a clinical stage oncology company, which focuses on developing precision oncology therapies. Its products include the AO-252 TACC3 inhibitor programme and the STAT-6 siRNA programme. The company also conducts clinical development activities, including Phase I clinical trials. Coiled Therapeutics plc was formerly known as Roquefort Therapeutics plc and changed its name to Coiled Therapeutics plc in March 2026. The company is based in London, United Kingdom.
Recent COIL News & Updates
No updates
